SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-227562
Filing Date
2022-08-23
Accepted
2022-08-23 16:45:41
Documents
8
Period of Report
2022-08-23

Document Format Files

Seq Description Document Type Size
1 6-K d340825d6k.htm 6-K 11033
2 EX-99.1 d340825dex991.htm EX-99.1 106306
3 EX-99.2 d340825dex992.htm EX-99.2 835070
4 EX-99.3 d340825dex993.htm EX-99.3 402285
5 EX-99.4 d340825dex994.htm EX-99.4 736223
6 EX-99.5 d340825dex995.htm EX-99.5 337642
7 GRAPHIC g340825g0822224857166.jpg GRAPHIC 33388
8 GRAPHIC g340825g0822231557044.jpg GRAPHIC 33388
  Complete submission text file 0001193125-22-227562.txt   2521772
Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Filer) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-56241 | Film No.: 221188086
SIC: 2833 Medicinal Chemicals & Botanical Products